Details for 2016780526

Up to date per 01.04.2026

Actions

Title / Product Name

BLUTBASIERTE BIOMARKER DER TUMOREMPFINDLICHKEIT GEGEN PD-1-ANTAGONISTEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016780526

EP Publication Number

3283882

E-Number

1346073

Language

PCT Number

US16027014

Publication Date

21.02.2018 A

16.12.2020 B1

Registration Date

16.12.2020

AT Publication Date

15.01.2021

Application Date

12.04.2016

Registration Number

Priorities

17.04.2015

201562149333 P

IPC

G01N 33/543 20060101AFI20181203BHEP

Maximum Duration of Protection

12.04.2036

Owner

Merck Sharp & Dohme Corp.126 East Lincoln Avenue Rahway, NJ 07065-0907US

Representative

No representatives present

Inventor

AYERS, Mark770 Sumneytown Pike West Point, Pennsylvania 19486US

LUNCEFORD, Jared1212 E High Ridge Drive Washington, Utah 84780US

LOBODA, Andrey33 Avenue Louis Pasteur Boston, Massachusetts 02115-5727US

NEBOZHYN, Michael770 Sumneytown Pike West Point, Pennsylvania 19486US

MCCLANAHAN, Terrill, K.901 S. California Avenue Palo Alto, California 94304US

HIRSCH, Heather9 Rice Street Apt. 2 Brookline, Massachusetts 02445US